EMA Authorised: Azopt (brinzolamide) — Novartis Europharm Limited

View source ↗

Summary

EMA authorised Azopt, brinzolamide 1% suspension, for open-angle glaucoma and ocular hypertension in the European Union. Novartis Europharm Limited is listed as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• Azopt (brinzolamide)

Snippet

Status: Authorised. Therapeutic area: Glaucoma, Open-Angle;Ocular Hypertension. MAH: Novartis Europharm Limited. Decision date: 09/02/2026